Home ›
Companies in Liquidation ›
Dragonfly Biosciences Limited Is Dragonfly Biosciences Limited in compulsory liquidation?
Last verified 11 July 2026
Yes, Dragonfly Biosciences Limited (company number 10842065) entered compulsory liquidation on 1 July 2026, by order of the court. S Brindley of Leonard Curtis was appointed as liquidator.
Do you deal with companies like Dragonfly Biosciences Limited? Add up to 5 companies free. We'll email you the day one enters administration.
Free, no card. We'll send a one-click sign-in link, no password to remember.
Prefer the earlier signs? Protect catches the pattern that builds, well before it's official. See how it works →
Dragonfly Biosciences Limited is now in compulsory liquidation. Below are the key dates, the directors, the public-record timeline that led here, and what the liquidation means if you are a creditor, employee, customer or supplier.
How the case progressed
Administration
12 July 2024
Compulsory liquidation
1 July 2026 · Leonard Curtis
Company at a glance
| Status | In Compulsory Liquidation |
|---|
| Company number | 10842065 |
|---|
| Incorporated | 29 June 2017 (9 years old) |
|---|
| Registered office | 5th Floor Grove House, 248a Marylebone Road, London, NW1 6BB |
|---|
| Nature of business (SIC) | 64209: Activities of other holding companies n.e.c. |
|---|
| Date entered compulsory liquidation | 1 July 2026 |
|---|
| Liquidator | S Brindley, Leonard Curtis (licensed insolvency practitioner) |
|---|
| Official notice | View the official notice ↗ |
|---|
| Public register | View filing history ↗ |
|---|
About the business
Dragonfly Biosciences Limited is a UK limited company based in London, incorporated in 2017 and 9 years old when the liquidator was appointed. Its registered activity is activities of other holding companies n.e.c. (SIC 64209). There have been 11 director appointments since incorporation, of which 1 was on the board when the liquidator was appointed, alongside 1 person with significant control. 2 charges have been registered against the company, all of which are recorded as satisfied.
Directors
11 people have been appointed as directors of Dragonfly Biosciences Limited.
DirectorStatusAppointedResigned
+5 former directors · resigned 2019 to 2021
A director resignation shortly before an insolvency is a matter of public record; it does not by itself imply wrongdoing.
Persons with significant control
Individuals or entities with significant influence or control.
Dragonfly Biosciences Limited Australia 9\Previously Siburan Resources Ltd)
corporate entity person with significant control
Ownership of shares 75-100%
2 ceased controls
- Mr Zbigniew Wronski · ceased 19 Jul 2021
- Radostina Draganova Nikolova · ceased 19 Jul 2021
Charges register
Secured creditors and encumbrances against the company. 0 outstanding · 2 satisfied.
Status · Creditor · Type · Dates
SatisfiedLucid Trustees Services Limited
A registered charge · Created 26 Jul 2019 · Satisfied 16 Nov 2021
SatisfiedLucid Trustee Services Limited
A registered charge · Created 26 Jul 2019 · Satisfied 16 Nov 2021
What happened
EventDateType
Notice of a court order ending Administration23 July 2026AM25
Compulsory liquidationStatus1 July 2026
Administrator's progress report29 January 2026AM10 Administrator's progress report24 July 2025AM10 Notice of extension of period of Administration20 May 2025AM19
+82 earlier events · 2017 to 2025
Administrator's progress report4 February 2025AM10 Notice of deemed approval of proposals26 September 2024AM06
Statement of administrator's proposal3 September 2024AM03 Appointment of an administrator12 July 2024AM01 Registered office address changed12 July 2024AD01 Compulsory strike-off action has been suspended12 June 2024DISS16(SOAS) First Gazette notice for compulsory strike-off28 May 2024GAZ1 Termination of appointment as a secretary15 January 2024TM02 Termination of appointment as a director15 January 2024TM01 Appointment as a director9 November 2023AP01 Termination of appointment as a director9 November 2023TM01 Appointment as a director6 November 2023AP01 Termination of appointment as a director12 October 2023TM01 Termination of appointment as a director12 October 2023TM01 Confirmation statement made with no updates28 September 2023CS01 Group of companies' accounts made up15 April 2023AA Notification as a person with significant control5 October 2022PSC02 Appointment as a secretary14 September 2022AP03 Appointment as a director14 September 2022AP01 Confirmation statement made with no updates31 August 2022CS01 Appointment as a director21 March 2022AP01 Current accounting period extended15 March 2022AA01 Termination of appointment as a secretary16 November 2021TM02 Cessation as a person with significant control16 November 2021PSC07 Cessation as a person with significant control16 November 2021PSC07 Satisfaction of charge in full16 November 2021MR04 Satisfaction of charge in full16 November 2021MR04 Director's details changed16 November 2021CH01 Termination of appointment as a director14 September 2021TM01 Termination of appointment as a director14 September 2021TM01 Termination of appointment as a director14 September 2021TM01 Confirmation statement made with updates19 August 2021CS01 Registered office address changed19 August 2021AD01 Confirmation statement made with updates14 August 2021CS01 Second filing of a statement of capital following an allotment of shares6 August 2021RP04SH01 Group of companies' accounts made up26 July 2021AA Statement of capital following an allotment of shares22 July 2021SH01 Confirmation statement made with updates22 July 2021CS01 Memorandum and Articles of Association18 May 2021MA Confirmation statement made with updates31 March 2021CS01 Statement of capital following an allotment of shares31 March 2021SH01 Statement of capital following an allotment of shares11 February 2021SH01 Statement of capital following an allotment of shares9 February 2021SH01 Confirmation statement made with updates9 February 2021CS01 Accounts for a small company made up17 November 2020AA Confirmation statement made with updates7 October 2020CS01 Statement of capital following an allotment of shares7 October 2020SH01 Statement of capital following an allotment of shares1 October 2020SH01 Confirmation statement made with updates30 September 2020CS01 Appointment as a director23 September 2020AP01 Statement of capital following an allotment of shares12 March 2020SH01 Confirmation statement made with updates12 March 2020CS01 Confirmation statement made with updates16 January 2020CS01 Second filing of a statement of capital following an allotment of shares9 January 2020RP04SH01 Confirmation statement made with updates16 December 2019CS01 Second filing of a statement of capital following an allotment of shares6 December 2019RP04SH01 Statement of capital following an allotment of shares26 November 2019SH01 Statement of capital following an allotment of shares14 October 2019SH01 Registration of charge , created16 August 2019MR01 Registration of charge , created15 August 2019MR01 Group of companies' accounts made up16 July 2019AA Confirmation statement made with updates10 July 2019CS01 Termination of appointment as a director9 July 2019TM01 Appointment as a secretary9 July 2019AP03 Confirmation statement made with updates3 July 2019CS01 Notification as a person with significant control18 June 2019PSC01 Previous accounting period shortened31 May 2019AA01 Total exemption full accounts made up28 May 2019AA Confirmation statement made with updates14 May 2019CS01 Confirmation statement made with updates8 May 2019CS01 Change of details as a person with significant control10 September 2018PSC04 Confirmation statement made with updates6 September 2018CS01 Appointment as a director19 March 2018AP01 Appointment as a director19 March 2018AP01 Appointment as a director5 January 2018AP01 Statement of capital following an allotment of shares13 December 2017SH01 Statement of capital following an allotment of shares13 December 2017SH01 Statement of capital following an allotment of shares13 December 2017SH01 Statement of capital following an allotment of shares13 December 2017SH01 Incorporation29 June 2017NEWINC What this means for you
If you are a creditor
Submit your proof of debt to the liquidator (Leonard Curtis). Once liquidation begins, no creditor can start or continue legal action without the court's permission. Unsecured creditors rank after secured and preferential creditors and are usually paid last, often only a portion.
Owed money by a company in liquidation →If you are an employee
Employees are preferential creditors for certain unpaid wages and holiday pay, and may be able to claim from the Redundancy Payments Service if roles are made redundant.
Employee rights and redundancy pay →If you are a customer
Deposits paid are usually unsecured claims. Contracts may be terminated by the liquidator. Contact the liquidator about outstanding work or refunds.
What customers can recover →If you are a supplier
Goods supplied before the liquidation began are an unsecured claim. Check whether any retention-of-title clause lets you identify and recover specific goods.
How retention of title works →Don't be the last to know next time
Most suppliers only find out a customer has failed once it is announced. By then it is too late. Protect monitors every company you sell to and emails you as the warning signs build, well before it becomes official. We can't stop a customer failing, but you'll never be the last to know, and you'll know you did all you could.
See how Protect works, £24/mo →Other companies in compulsory liquidation
Related guides
The bigger picture
Frequently asked questions
- Is Dragonfly Biosciences Limited in compulsory liquidation?
- Yes. Dragonfly Biosciences Limited (company number 10842065) entered compulsory liquidation on 1 July 2026, by order of the court. S Brindley of Leonard Curtis was appointed as liquidator.
- Who is the liquidator of Dragonfly Biosciences Limited?
- S Brindley, a licensed insolvency practitioner at Leonard Curtis, was appointed liquidator of Dragonfly Biosciences Limited on 1 July 2026. Creditors can contact the liquidator directly to submit a claim.
- What does Dragonfly Biosciences Limited do?
- Dragonfly Biosciences Limited's registered nature of business is activities of other holding companies n.e.c. (SIC 64209).
- Where is Dragonfly Biosciences Limited based?
- Dragonfly Biosciences Limited's registered office is 5th Floor Grove House, 248a Marylebone Road, London, NW1 6BB. The registered office is the address held on the public register, which is not always the trading address.
- When was Dragonfly Biosciences Limited founded?
- Dragonfly Biosciences Limited was incorporated on 29 June 2017, 9 years before the liquidator was appointed.
- What is Dragonfly Biosciences Limited's company number?
- Dragonfly Biosciences Limited's registered company number is 10842065.
- Who has significant control of Dragonfly Biosciences Limited?
- 1 active person with significant control over Dragonfly Biosciences Limited is on the register: Dragonfly Biosciences Limited Australia 9\Previously Siburan Resources Ltd).
- What does liquidation mean for creditors of Dragonfly Biosciences Limited?
- Liquidation is the formal wind-up of a company. Once it begins, the liquidator collects assets, settles claims in statutory order (secured, preferential, then unsecured) and distributes whatever remains. Unsecured creditors often recover only a portion of what they are owed, and sometimes nothing.
- How long does liquidation take?
- Most liquidations run for 12 to 24 months, longer where the company has complex assets, litigation, or ongoing trading. Annual progress reports are filed by the liquidator until the company is dissolved at the end of the process.
- Will creditors get paid in Dragonfly Biosciences Limited's liquidation?
- Secured creditors are paid from the assets they hold a charge over. Preferential creditors (employee wages up to limits, pension contributions, HMRC for certain taxes) come next. Unsecured creditors share whatever remains, which may be nothing. The Statement of Affairs, when filed, sets out the liquidator's estimate at the point of appointment.
Report an error on this page·Not financial, credit or legal advice.